JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 34 No. 4 695-696
© 1993 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stabin, M. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stabin, M. G.

Radiation Dose to the Upper Spine from Therapeutic Administrations of Iodine-131-Sodium Iodide

Michael G. Stabin

Radiation Internal Dose Information Center, Medical Sciences Division, Oak Ridge Institute for Science and Education, Oak Ridge, Tennessee

Correspondence: For correspondence or reprints contact: Michael G. Stabin, Radiation Internal Dose Information Center, Medical Sciences Division, Oak Ridge Institute for Science and Education, P.O. Box 117, Oak Ridge, TN 37831-0117.

ABSTRACT

Thyroid cancer patients sometimes receive conventional external irradiation to the neck in addition to radioactive iodine therapy. In these situations, knowledge of the radiation dose already received by the spine in the neck area from the radioiodine administration can be an aid in treatment planning. This paper gives an estimate of the radiation dose to the upper spine from administration of 3700 MBq of 131I-sodium iodide. Monte Carlo codes used to estimate radiation dose from internal emitters usually give absorbed doses to the whole spine or marrow. One such code was modified to give a dose only to the upper spine region near the thyroid. Calculations assumed a thyroid uptake of 10% of administered activity and retention with a 35-hr effective half-time. Activity in the remainder of the body was assumed to clear with a 6-hr half-time to urine. Under these assumptions, the dose to this upper spine region was about 200 mGy.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1993 by the Society of Nuclear Medicine.